基本信息 产品详情 公司简介 推荐产品
网站主页 BM 957 化合物 BM 957
  • 化合物 BM 957|T10577|TargetMol

化合物 BM 957|T10577|TargetMol

BM 957
1391107-54-2
10600 25mg 起订
上海 更新日期:2025-11-17

TargetMol中国(陶术生物)

VIP2年
联系人:邵小姐
手机:15002134094 拨打
邮箱:marketing@targetmol.cn

产品详情:

中文名称:
化合物 BM 957
英文名称:
BM 957
CAS号:
1391107-54-2
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
产品类别:
抑制剂
货号:
T10577

Product Introduction

Bioactivity

名称BM 957
描述BM 957 is an effective Bcl-2 and Bcl-xL inhibitor (Kis: 1.2 and <1 nM; IC50s: 5.4 and 6.0 nM).
体外活性In these two cancer cell lines (H1417 and H146 cell lines), BM 957 has IC50 values of 21 nM and 22 nM, respectively. All these compounds induce cell death in a dose-dependent manner but have different potencies. While BM 957 and 31 are several times more potent than 1 and 2. BM 957 at 10 nM, 28 at 100 nM and 2 at 30 nM all induce clear cleavage of PARP and activation of caspase-3 and have similar effects.
体内活性It is found that BM 957 (Compound 30) at 25 mg/kg daily, intravenous dosing, 5 days a week for 2 weeks are well tolerated in SCID mice and the animals have less than 10% of weight loss. Higher doses of 50 mg/kg for BM 957 cause more than 10% of weight loss. Mice bearing H146 tumors are given a single i.v. the dose of BM 957 at 25 mg/kg. BM 957 at 25 mg/kg is capable of achieving complete tumor regression. Of 7 mice treated with BM 957, all mice are tumor-free at day 47 and five (71%) remained tumor-free on day 58. Similar to the data obtained from our MTD experiment, BM 957 is well-tolerated in tumor-bearing animals. All treated animals experienced less than 10% weight loss compared to the vehicle control and all regained their weight quickly after the treatments are finished. This in vivo experiment thus establish that BM 957 achieves complete and durable tumor regression in the H146 xenograft tumor model.
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
关键字BM-957 | BM957 | BM 957 | Bcl-xL | Bcl-2
相关产品Navitoclax | Diphenyl disulfide | Thymoquinone | Venetoclax | Gossypol (acetic acid) | (S)-(+)-Ibuprofen | Sonrotoclax TFA | Erianin | Gossypol | UMI-77 | Lisaftoclax | Allethrin
BM 957|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。

成立日期 (13年)
注册资本 589.8595万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,天然产物,生物化工,化学试剂,生物技术服务

化合物 BM 957相关厂家报价

内容声明
拨打电话 立即询价